Zlotta AR - Search Results

1

Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors.

Alkhateeb SS, Van Rhijn BW, Finelli A, van der Kwast T, Evans A, Hanna S, Vajpeyi R, Fleshner NE, Jewett MA, Zlotta AR. Alkhateeb SS, et al. Among authors: zlotta ar. J Urol. 2010 Jul;184(1):81-6. doi: 10.1016/j.juro.2010.03.022. Epub 2010 May 15. J Urol. 2010. PMID: 20478593

2

Repeat prostate biopsy: who, how and when?. a review.

Djavan B, Remzi M, Schulman CC, Marberger M, Zlotta AR. Djavan B, et al. Among authors: zlotta ar. Eur Urol. 2002 Aug;42(2):93-103. doi: 10.1016/s0302-2838(02)00256-7. Eur Urol. 2002. PMID: 12160578 Review.

3

An artificial neural network for prostate cancer staging when serum prostate specific antigen is 10 ng./ml. or less.

Zlotta AR, Remzi M, Snow PB, Schulman CC, Marberger M, Djavan B. Zlotta AR, et al. J Urol. 2003 May;169(5):1724-8. doi: 10.1097/01.ju.0000062548.28015.f6. J Urol. 2003. PMID: 12686818

4

An artificial neural network to predict the outcome of repeat prostate biopsies.

Remzi M, Anagnostou T, Ravery V, Zlotta A, Stephan C, Marberger M, Djavan B. Remzi M, et al. Urology. 2003 Sep;62(3):456-60. doi: 10.1016/s0090-4295(03)00409-6. Urology. 2003. PMID: 12946746 Clinical Trial.

5

Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.

Zlotta AR, Roumeguère T, Ravery V, Hoffmann P, Montorsi F, Türkeri L, Dobrovrits M, Scattoni V, Ekane S, Bollens R, Vanden Bossche M, Djavan B, Boccon-Gibod L, Schulman CC; European Society for Urological Oncology. Zlotta AR, et al. Eur Urol. 2004 Jul;46(1):42-9. doi: 10.1016/j.eururo.2004.03.021. Eur Urol. 2004. PMID: 15183546

6

Prostate cancer prevention: past, present, and future.

Fleshner N, Zlotta AR. Fleshner N, et al. Among authors: zlotta ar. Cancer. 2007 Nov 1;110(9):1889-99. doi: 10.1002/cncr.23009. Cancer. 2007. PMID: 17893870 Free article. Review.

7

When and how to treat superficial and muscle-invasive bladder cancer.

Zlotta AR. Zlotta AR. Eur Urol. 2007 Dec;52(6):1554-7. doi: 10.1016/j.eururo.2007.09.033. Epub 2007 Sep 25. Eur Urol. 2007. PMID: 17904728 No abstract available.

8

Pharmacotherapy for prostate cancer: the role of hormonal treatment.

Shahani R, Fleshner NE, Zlotta AR. Shahani R, et al. Among authors: zlotta ar. Discov Med. 2007 Aug;7(39):118-24. Discov Med. 2007. PMID: 18093474 Free article.

9

Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection.

Al-Ghamdi AM, Lockwood G, Toi A, Kulkarni GS, Evans A, Finelli A, Zlotta AR, Fleshner N. Al-Ghamdi AM, et al. Among authors: zlotta ar. J Urol. 2008 Apr;179(4):1332-4. doi: 10.1016/j.juro.2007.11.067. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289588

10

The REDUCE trial: chemoprevention in prostate cancer using a dual 5alpha-reductase inhibitor, dutasteride.

Musquera M, Fleshner NE, Finelli A, Zlotta AR. Musquera M, et al. Among authors: zlotta ar. Expert Rev Anticancer Ther. 2008 Jul;8(7):1073-9. doi: 10.1586/14737140.8.7.1073. Expert Rev Anticancer Ther. 2008. PMID: 18588452 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

265 results

Search Page